Dong-E E-Jiao Independent Director Sun Xiaobo's 2025 Performance Report Released, Focusing on Related Party Transactions and Equity Incentives

Sina Finance Data: Shenda Aijiao Co., Ltd. recently disclosed the 2025 annual work report of independent director Sun Xiaobo. The report shows that during his tenure from January 1 to December 22, 2025, Sun Xiaobo fulfilled his duties diligently and actively performed his responsibilities as an independent director. In 2025, he personally attended 11 board meetings, 4 nomination committee meetings, 6 audit committee meetings, 6 remuneration and assessment committee meetings, and 5 independent director special meetings, voting in favor of all proposals without raising objections.

The report highlights Sun Xiaobo’s focus on key matters in his duties. Regarding related-party transactions, he participated in reviewing and approved the company’s expected daily related-party transactions for 2025 and 2026, as well as proposals such as the establishment of China Resources Pharmaceutical Industry Investment Fund Phase II, believing that the related transactions follow fairness principles and do not harm the interests of the company or minority shareholders. Concerning periodic reports, he supervised the authenticity, accuracy, and completeness of the company’s timely prepared disclosures, including the 2024 annual report and quarterly reports for 2025. Regarding appointment of institutions, he approved the continued engagement of KPMG Huazhen Certified Public Accountants LLP as the company’s audit firm for 2025.

Additionally, Sun Xiaobo performed supervisory duties on matters such as the election and appointment of directors and senior management, senior management compensation assessments, and the first phase of the restricted stock incentive plan. The report states that the first phase of the restricted stock incentive plan has completed its initial grant registration, aiming to establish a long-term incentive mechanism. In the report, Sun Xiaobo expressed that during his tenure, he received full support and cooperation from the company, and his right to be informed was protected. His overall evaluation is that the company’s operations are standardized, and he hopes the company will continue to operate steadily and deliver returns to investors. Due to personal reasons, Sun Xiaobo has ceased to serve as an independent director of the company since December 22, 2025.